Substance / Medication

Adefovir

Overview

Active Ingredient
adefovir
RxNorm CUI
16521

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

198 trials linked to this intervention

198
Total Trials
24
Recruiting
66
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B: A meta-analysis.
Luo Qing, Deng Yong, Cheng Feifei et al. · Medicine (Baltimore) · 2016
PMID: 27977591Meta-AnalysisFull text (PMC)
Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma.
Zhong Jian Hong, Li Le Qun, Wu Liu Cheng · Cochrane Database Syst Rev · 2011
PMID: 22161435Meta-Analysis
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.
Katz Lior H, Tur-Kaspa Ran, Guy Daniel G et al. · Cochrane Database Syst Rev · 2010
PMID: 20614442Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Adefovir (substance)
SNOMED CT
412072006
UMLS CUI
C0050175
RxNorm CUI
16521

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
198
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.